Clinical Trials Logo

Filter by:
NCT ID: NCT05957029 Completed - Clinical trials for To Verify Tissue Heating and Temperature Stability and Safety Throughout RF Treatment Duration Applied on the Face

Evaluation of Thermal Outcome and Safety of Nuera Tight RF System

Start date: June 22, 2023
Phase: N/A
Study type: Interventional

The purpose of the study is to verify tissue heating, temperature stability and safety of the Nuera Tight RF device during and after treatment session applied on the face.

NCT ID: NCT05956925 Completed - Hypertension Clinical Trials

MOBILE Intervention in College Students With Elevated Blood Pressure

MOBILE
Start date: December 3, 2020
Phase: N/A
Study type: Interventional

The investigators' long-term goal is to develop tailored interventions to influence self-management behaviors in young adults with elevated blood pressure (BP). The investigators seek to test an intervention, mHealth to Optimize BP Improvement (MOBILE), that takes advantage of existing applications and our prior work to allow participants to (1) perform self-measured BP monitoring; (2) receive feedback from a cloud-based cardiovascular disease (CVD) detection platform; and (3) receive tailored text messages that encourage engagement in BP reduction behavior. mHealth technology provides an ideal way to deliver healthcare interventions to young adults. Text messaging is especially appealing to college students, more than 91% of whom use smartphones as their main communication device. For this study, the investigators will recruit 42 college students, ages 18 to 29, with elevated BP to participate in formative developmental project and then a 4-week two-armed trial of MOBILE. The aims of this study are: Aim 1. To refine the MOBILE intervention during a formative phase involving 8-10 students. Outcomes will include finalized motivation-level-tailored text messages designed to prompt behavior change and a self-administered motivational scale to be employed in the Aim 2 and Exploratory Aim study. Aim 2. To evaluate the feasibility of implementing the MOBILE intervention in 32 college students with elevated BP. The investigators will operationalize MOBILE feasibility as: (a) acceptability to participants, (b) participation rate, (c) texts delivered and opened, (d) fidelity to daily BP measurement protocol, (e) reported technical problems and challenges, and (f) recruitment and attrition rates. Exploratory Aim. To examine the preliminary impact of the MOBILE intervention on BP reduction (primary outcome) along with sodium intake and hypertension (HTN) knowledge improvement (secondary outcomes) among 32 college students with elevated BP. Hypothesis: The intervention group will have a significantly greater reduction in BP and sodium intake and greater increase in HTN knowledge from baseline to completion, compared to control group.

NCT ID: NCT05956808 Completed - Clinical trials for Hearing Loss, Sensorineural

Phonak Behind-The-Ear Quality Evaluation

Start date: July 17, 2023
Phase: N/A
Study type: Interventional

Subjective listening effort and objective speech intelligibility will be evaluated with a new generation of a Phonak BTE (Behind-The-Ear) hearing aid.

NCT ID: NCT05956782 Completed - Quality of Life Clinical Trials

Breathe Easier II: A Dyad-based Multiple Behavior Intervention

BE
Start date: June 15, 2022
Phase: N/A
Study type: Interventional

This pilot randomized control trial (RCT) will test a 12-week, multiple behavior intervention physical activity and stress management for survivors with early stage lung cancer (stages I-III) and their family members (1 survivor + 1 family member or friend = 1 dyad). The long-term goal of this research is to improve health outcomes for survivors of lung cancer and their family members. The goals of the intervention, Breathe Easier, are symptom reduction (less breathlessness, less fatigue, less stress) and change in multiple behaviors (increase in stress management and increase in physical activity, and decrease tobacco use - if appropriate). Our aim is: To conduct a 6-month, two-group, pilot randomized control trial intervention study with a pre- and post-test study design to estimate preliminary intervention effects on (a) reduction of symptoms (breathlessness, fatigue, and stress) in survivors of non small cell lung cancer (stages I-III) and family members or friends; (b) increase in physical activity behaviors immediately following the intervention and at 3-months; (c) increase in stress management strategies immediately following the intervention and at 3-months; (d) reduction in smoking behavior among participants who smoke tobacco products at study entry immediately following the intervention at 3-months.

NCT ID: NCT05956678 Completed - Clinical trials for Circadian Rhythm Disorders

Implementing and Sustaining a Sleep Treatment to Improve Community Mental Health Part 3: Sustainment

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

Research on the sustainment of implemented evidence-based psychological treatments in routine practice settings, such as community mental health centers, is limited. The goal of this study is to test sustainment predictors, mechanisms, and outcomes of the Transdiagnostic Intervention for Sleep and Circadian Dysfunction (TranS-C) in community mental health centers after implementation efforts have ended. CMHC providers have been trained to deliver a "Standard" or "Adapted" version of TranS-C. Researchers will compare these two groups to evaluate differences--and possible mechanisms--with respect to sustainment outcomes.

NCT ID: NCT05956353 Completed - Prevention Clinical Trials

Stories for Change: Early Detection Can Save Lives

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the Stories for Change (S4C) Cancer Prevention digital storytelling intervention for acceptability and socio-behavioral constructs to increase cancer screening among Hispanic or Latino individuals.

NCT ID: NCT05955872 Completed - Clinical trials for Focal Segmental Glomerulosclerosis (FSGS)

A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

Start date: July 19, 2023
Phase: Phase 1
Study type: Interventional

The purpose of the study is to evaluate the relative bioavailability (BA) and the effect of food on the pharmacokinetics (PK), and the safety and tolerability of VX-147 test tablet formulation.

NCT ID: NCT05955586 Completed - Healthy Volunteer Clinical Trials

A Study to Assess the Intrapulmonary Pharmacokinetics (PK) of SPR719 by Comparing the Plasma, Epithelial Lining Fluid, and Alveolar Macrophage Concentrations Following the Oral Administration of Multiple Doses of SPR720 in Healthy Volunteers.

Start date: August 1, 2023
Phase: Phase 1
Study type: Interventional

The primary purpose of this study is to evaluate the intrapulmonary PK, including epithelial lining fluid (ELF) and alveolar macrophages (AM) concentrations, of SPR719 compared to plasma concentrations of SPR719 (the active moiety in plasma of the prodrug SPR720) after oral administration of SPR720 1000 milligram (mg) capsules every 24 hours for 7 consecutive doses.

NCT ID: NCT05955560 Completed - Clinical trials for Non-invasive Urine Output Management

Male External Catheters' Comparison of Comfort and Efficacy

MECCE
Start date: June 12, 2023
Phase: N/A
Study type: Interventional

A Prospective, Randomized, Crossover, Single-blind, Single Center Healthy Volunteer Study conducted over 1 day, with 2 voids using the PW Male external catheter vs. comparator Sage PrimoFitâ„¢. This study is designed to assess the performance, comfort, and ease of use of the PW Male external catheter as compared to the comparator product.

NCT ID: NCT05955183 Completed - Clinical trials for Healthy Participants

Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..

Start date: July 27, 2023
Phase: Phase 1
Study type: Interventional

This study will evaluate the pharmacokinetics (PK), pharmacodynamics (PD), safety, and tolerability of AZD5055 after single and multiple doses, orally administered in healthy Japanese and Chinese participants.